UNSPSC 51334316: Zuclopenthixol hydrochloride

This classification denotes the hydrochloride form of an antipsychotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 47ISU063SG. European Medicines Agency schedules Zuclopenthixol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00195MIG. Zuclopenthixol generally arises in the molecular formula C22H25CLN2OS.

UNSPSC 51334316 Zuclopenthixol hydrochloride is a Commodity code that nominally describes a specific antipsychotic pharmaceutical, but the recent procurement activity captured under this code shows limited direct alignment with the code's scope. State and local governments are not actively soliciting zuclopenthixol hydrochloride itself; instead, the code's most recent recorded opportunity involves a fundamentally different class of products — naloxone and drug deactivation systems — acquired for community health and harm-reduction purposes rather than psychiatric medication dispensing. The issuing body in the recent record is Seminole County, Florida, a county-level jurisdiction pursuing acquisition through a competitive bidding process (IFB) for ongoing supply contracts.

Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement included E-Verify compliance, drug-free workplace certification, standard insurance coverage requirements (workers' compensation, commercial general liability, professional liability), and a two-year initial term with a one-year renewal option; a three-month probationary termination clause was built into the contract structure. The response deadline was July 26, 2023, at 2:00 pm, with a question cutoff of July 21, 2023. Potential FEMA funding was identified, introducing federal compliance overlays such as the Clean Air Act and Federal Water Pollution Control Act. Given the mismatch between the code's nominal scope (zuclopenthixol hydrochloride) and the actual procurement (naloxone and drug deactivation systems), this code shows little relevant recent activity for vendors seeking to serve state and local pharmaceutical or medical supply procurement aligned with the commodity's stated name.